2. Academic Validation
  3. TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

TCL1 transgenic mice as a model for CD49d-high chronic lymphocytic leukemia

  • Leukemia. 2020 Sep;34(9):2498-2502. doi: 10.1038/s41375-020-0759-3.
Eva Szenes  # 1,  Andrea Härzschel  # 1 2,  Sarah Decker 2,  Erika Tissino 3,  Justine Pischeli 1,  Julia Christine Gutjahr 1,  Sandra Kissel 2,  Sandra Pennisi 2,  Jan Philip Höpner 1,  Alexander Egle 1,  Nadja Zaborsky 1,  Christine Dierks 2,  Marie Follo 2,  Alexandre Chigaev 4,  Antonella Zucchetto 3,  Richard Greil 1,  Valter Gattei 3,  Tanja Nicole Hartmann 5 6
Affiliations

Affiliations

  • 1 Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria.
  • 2 Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • 3 Clinical and Experimental Onco-Hematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
  • 4 Department of Pathology and Cancer Center, University of New Mexico, Albuquerque, NM, USA.
  • 5 Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Salzburg, Austria. tanjanhartmann@gmail.com.
  • 6 Department of Internal Medicine I, Medical Center and Faculty of Medicine, University of Freiburg, Freiburg, Germany. tanjanhartmann@gmail.com.
  • # Contributed equally.
PMID: 32086446 DOI: 10.1038/s41375-020-0759-3
Figures
Products